CC BY-NC-ND 4.0 · Indian Journal of Medical and Paediatric Oncology 2021; 42(01): 021-024
DOI: 10.1055/s-0041-1729734
Courting Controversy

Can Cancer Survivors Donate Convalescent Plasma for the Treatment of COVID-19?

Ajit Venniyoor
1  National Oncology Centre, The Royal Hospital, Muscat, Sultanate of Oman
› Author Affiliations

Case Vignette

SS is a 50-year-old female treated for stage III colon cancer in 2010 and on a 6-monthly follow-up. She missed her scheduled review in July 2020 and informed that she could not come on for her appointment due to coronavirus disease 2019 (COVID-19) infection, which affected her whole family, all of whom had mild symptoms and recovered uneventfully. I suggested that she could now donate convalescent plasma (CP) for the treatment of seriously ill COVID-19 patients, and she was immediately interested. I advised her to go to the hospital’s blood transfusion center and volunteer. Later, I had a call from the transfusion medical officer asking me to clarify whether cancer survivors can donate blood or blood products.



Publication History

Publication Date:
18 May 2021 (online)

© 2021. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India